Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
The Daily Biotech Pulse: Illumina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In
Here's a roundup of top developments in the biotech space over the last 24 hours:
5 Stocks To Watch For December 27, 2021
Some of the stocks that may grab investor focus today are:
EXCLUSIVE: NeuBase Therapeutics Chairman & CEO, Dietrich Stephan, PhD Now Interviewing On Benzinga’ Live Tv
Click To Tune In Here... https://www.youtube.com/watch?v=-NFQEIRCg0Q
NeuBase Therapeutics To Present At Chardan Genetic Medicines Conference Oct. 5 At 11:30 a.m. EDT
NeuBase Therapeutics, Inc. (NASDAQ:NBSE) (“NeuBase”), a biotechnology platform company Drugging the Genome™ to address disease at the base level using a new class of precision genetic medicines,
Stocks That Hit 52-Week Lows On Friday
On Friday morning, 155 companies achieved new lows for the year.
NeuBase Therapeutics Q3 EPS $(0.29) Down From $(0.18) YoY
NeuBase Therapeutics (NASDAQ:NBSE) reported quarterly losses of $(0.29) per share. This is a 61.11 percent decrease over losses of $(0.18) per share from the same period last year.
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen’s Anemia Drug, Corvus Shelves COVID Study
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 15)